Autolus Therapeutics plc(NASDAQ:AUTL) 
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company is developing AUTO1 and AUTO3 for B cell malignancies; AUTO2 and AUTO8 for the treatment of multiple myeloma; AUTO1/22 for the treatment of dual-targeting CAR-T; A...
Website: http://www.autolus.com
Founded: 2014
Full Time Employees: 290
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.47
H 1.51
L 1.31
C 1.33
V 1,736,981
10EMA 1.33
20EMA 1.33
60EMA 1.33
120EMA 1.33
250EMA 1.33